five prime therapeutics, inc product pipeline

1

Five Prime Therapeutics, Inc. - Product Pipeline Review

– 2015 Now Available at iData Insights

Five Prime Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct s, Five

Prime Therapeutics, Inc. - Product Pipeline Review - 2015, provides an overview of the Five Prime

Therapeutics, Inc.s pharmaceutical research and development focus. This report provides

comprehensive information on the current therapeutic developmental pipeline of Five Prime

Therapeutics, Inc. s, complete with comparative analysis at various stages, therapeutics assessment by

drug target, mechanism of action (MoA),

route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and

press releases, along with special features on late-stage and discontinued projects. Global Markets

Directs report features investigational drugs from across globe covering over 20 therapy areas and

nearly 3,000 indications. The report is built using data and information sourced from Global Markets

Directs proprietary databases, Company/University websites, SEC filings, investor presentations and

featured press releases from company/university sites and industry-specific third party sources, put

together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes

periodic updation following a stringent set of processes that ensures that all the profiles are updated

with the latest set of information. Additionally, processes including live news & deals tracking, browser

based alert-box and clinical trials registries tracking ensure that the most recent developments are

captured on a real time basis. The report enhances decision making capabilities and help to create

effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying

new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the

report may be removed or altered based on the availability and relevance of data for the indicated

disease. Scope - The report provides brief overview of Five Prime Therapeutics, Inc. including business

description,

key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Five

Prime Therapeutics, Inc.s human therapeutic division and enlists all their major and minor projects - The

report features product description and descriptive mechanism of action for key pipeline products along

with the products developmental history and major milestones - Special feature on out-licensed and

partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects

- Latest company statement - Latest news and deals relating to the Five Prime Therapeutics, Inc.s

pipeline products Reasons to buy - Evaluate Five Prime Therapeutics, Inc.s strategic position with total

access to detailed information on its product pipeline - Assess the growth potential of Five Prime

Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the

Five Prime Therapeutics, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in

those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio

gaps - Develop strategic initiatives by understanding the focus areas of Five Prime Therapeutics, Inc. and

exploit collaboration and partnership opportunities - Identify emerging players with potentially strong

product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers

and acquisitions effectively by identifying the most promising pipeline of Five Prime Therapeutics, Inc. -

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the

most attractive projects to enhance and expand business potential and scope - Explore the dormant and

2

discontinued projects of Five Prime Therapeutics, Inc. and identify potential opportunities in those areas

- Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-

page.php?id=124220/five-prime-therapeutics-inc-product-pipeline-review-2015

To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-

page.php?id=124220/five-prime-therapeutics-inc-product-pipeline-review-2015

Table of Contents

able of Contents 2

List of Tables 4

List of Figures 4

Five Prime Therapeutics, Inc. Snapshot 5

Five Prime Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

Five Prime Therapeutics, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Five Prime Therapeutics, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Pipeline Products - Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Five Prime Therapeutics, Inc. - Pipeline Products Glance 14

Five Prime Therapeutics, Inc. - Clinical Stage Pipeline Products 14

Phase I Products/Combination Treatment Modalities 14

3

Five Prime Therapeutics, Inc. - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Five Prime Therapeutics, Inc. - Drug Profiles 17

FPA-008 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

FP-1039 19



R&D Progress 19

FPA-144 21



R&D Progress 21

INBRX-110 23



R&D Progress 23

Monoclonal Antibodies for Cancer 24



4

R&D Progress 24

Monoclonal Antibodies for Solid Tumors 25



R&D Progress 25

Proteins for Asthma and Chronic Obstructive Pulmonary Disease 26



R&D Progress 26

Proteins for Central Nervous System Disorders 27



R&D Progress 27

Five Prime Therapeutics, Inc. - Pipeline Analysis 28

Five Prime Therapeutics, Inc. - Pipeline Products by Target 28

Five Prime Therapeutics, Inc. - Pipeline Products by Route of Administration 29

Five Prime Therapeutics, Inc. - Pipeline Products by Molecule Type 30

Five Prime Therapeutics, Inc. - Pipeline Products by Mechanism of Action 31

Five Prime Therapeutics, Inc. - Recent Pipeline Updates 32

Five Prime Therapeutics, Inc. - Dormant Projects 36

Five Prime Therapeutics, Inc. - Locations And Subsidiaries 37

Head Office 37

Appendix 38

Methodology 38

5

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

Read More http://www.idatainsights.com/reports-landing-page.php?id=124220/five-prime-

therapeutics-inc-product-pipeline-review-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading

market research information aggregator and marketing research consulting firm. We conduct both

primary and secondary research. Our work does not end with research it is also involved in distributing

reports for different companies . We provide actionable recommendations and provide our expertise for

business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and

discovery, and then be their guide in the implementation of changes that will make a difference to their

bottom line.

ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: [email protected] About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our

mission to provide timely services coupled with acute client care to create a long-lasting relationship

with you. We deliver on our promise to provide results that are essential to the success of your

company. We believe that by doing so, we will earn the trust of our clients for future projects

http://www.idatainsights.com/

five prime therapeutics, inc product pipeline

Documents